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Abstract
Background: Chronic lung infection with Pseudomonas aeruginosa remains a major cause of mortality and morbidity among
individuals with CF. Expression of mediators promoting recruitment and differentiation of B cells, or supporting antibody
production is poorly understood yet could be key to controlling infection.
Methods: BAFF was measured in BAL from children with CF, both with and without P. aeruginosa, and controls. Mice were
intra-nasally infected with P. aeruginosa strain LESB65 for up to 7 days. Cellular infiltration and expression of B cell
chemoattractants and B cell differentiation factor, BAFF were measured in lung tissue.
Results: BAFF expression was elevated in both P. aeruginosa negative and positive CF patients and in P. aeruginosa infected
mice post infection. Expression of the B cell chemoattractants CXCL13, CCL19 and CCL21 increased progressively post
infection.
Conclusions: In a mouse model, infection with P. aeruginosa was associated with elevated expression of BAFF and other B
cell chemoattractants suggesting a role for airway B cell recruitment and differentiation in the local adaptive immune
response to P. aeruginosa. The paediatric CF airway, irrespective of pseudomonal infection, was found to be associated with
an elevated level of BAFF implying that BAFF expression is not specific to pseudomonas infection and may be a feature of
the CF airway. Despite the observed presence of a potent B cell activator, chronic colonisation is common suggesting that
this response is ineffective.
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Introduction
Chronic lung disease is the major cause of morbidity and
mortality among individuals with Cystic Fibrosis [CF]. Prominent
among the causes of such lung disease is chronic infection with the
opportunistic pathogen Pseudomonas aeruginosa [1]. Immune defence
against respiratory tract pathogens is dependent upon a complex
interplay of both innate and adaptive components that may
prevent or clear infection. However CF is a leading example of an
illness in which this complex interplay between innate and
adaptive immunity is not protective as evidenced by long term
P. aeruginosa infection.
Production of pathogen-specific antibody by B lymphocytes is
normally an important mechanism of airway defence against P.
aeruginosa infection [2,3]. Studies, in mice and humans, have
characterised the specificity and magnitude of antibody responses
to P. aeruginosa infection [3] and notably antibody production to
vaccine candidates has been correlated with protection upon
subsequent P. aeruginosa challenge [4] but antibody production
does not correlate with protection in the CF airway.
To improve strategies for airway vaccine design and new
therapeutics against P. aeruginosa, a better understanding of
antibody induction in the airways is needed. However, the
mediators that promote recruitment and differentiation of B cells
to the lung or support airway antibody production during infection
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of Children with CF and in Lungs of Mice Infected with
are poorly understood, both with respect to P. aeruginosa and
airway pathogens in general [5]. We have previously reported
production of the B cell differentiation factor, B cell activating
factor of the TNF family [BAFF, also known as BLys or
TNFS13B] by human lung epithelia in response to viral infection
[6]. Studies using influenza infected mice show that homeostatic
chemokines including CXCL13, CCL19 and CCL21 are essential
for effective pulmonary defence, regulating B and T cell
recruitment to the airway, stimulating dendritic cells and
influencing formation of inducible bronchial associated lymphoid
tissues [iBALT] [7]. In mice infected with P. aeruginosa, Eppert et al
showed a possible role for CCL19 and CCL21 in regulating
lymphocyte or dendritic cell recruitment but only examined one
day post infection [8]. The BAFF response to ongoing airway P.
aeruginosa infection has not been studied, but recombinant BAFF,
used as an adjuvant, has been shown to enhance the airway
response to heat-killed P. aeruginosa in mice [9].
We firstly sought to establish if expression of BAFF is a feature
of the airway response to chronic bacterial infection, including P.
aeruginosa, analysing lower airway samples from children with CF,
with and without P. aeruginosa infection, compared to healthy
control patients. To validate our findings further we used a 7-day
murine respiratory inhalation model to establish stable infection of
the airways and study the inflammatory response to P. aeruginosa,
specifically with regards to the recruitment and potential
stimulation of B cells. In our murine respiratory inhalation model,
mice are challenged with the clinically relevant P. aeruginosa
Liverpool epidemic strain [LES] isolate LESB65, which establishes
a stable 7 day infection that is restricted to the airway [10]. In
contrast to models using non-colonising P. aeruginosa strains that
are rapidly cleared by components of the innate immune system or
more aggressive strains that cause sepsis and host death, this model
allows the lung response to in situ infection to develop over a longer
time period, such as occurs in CF [10].
Our results demonstrate for the first time the kinetics of B cell
chemoattractant and differentiation factor responses both follow-
ing P. aeruginosa infection and in relation to lung B cell recruitment
in a murine model. An elevated level of BAFF was found to be
associated with the paediatric CF airway, irrespective of the
presence or absence of pseudomonal infection, implying that the
expression is not specific to pseudomonas infection and may be a
feature of the CF airway. The importance of the B cell response in
the CF lung remains unclear and its effectiveness is complicated by
other factors predisposing to poor bacteria eradication such as
impaired mucocilary clearance.
Patients and Methods
Patient samples
Bronchoalveolar lavage [BAL] was obtained bronchoscopically
from CF patients who were being investigated electively for
persistent respiratory symptoms. Lower respiratory lavage fluid
was obtained non-bronchoscopically from the remainder of CF
patients and non-CF, healthy control patients, when anaesthetised
for routine elective surgery as described previously [11]. Micro-
biological analysis was conducted on BAL from all CF patients in
the microbiology department of this specialist hospital [BAL from
non-CF healthy control children was not sent for analysis]. Lavage
fluid was aliquoted and stored at 270uC until used for analysis.
Ethics Statement
The paediatric ethics committee in Liverpool approved the
study and all samples were collected following written informed
consent from parents [REC:]06/Q1502/142].
Mice
Female BALB/cOlaHsd mice were purchased from Harlan
Laboratories [Bicester, UK] and acclimatised for one week prior
to use. Mice used for infection experiments were between 9 and 12
weeks of age and were age matched for each experiment. The
U.K. Home Office approved the experimental protocols.
Infection of Mice
Animals were anaesthetised with a mixture of oxygen and
isofluorane and infected intranasally with 16106 CFU P. aeruginosa
LESB65 in 50 ml phosphate buffered saline [10].Mice did not
develop visible signs of disease and were culled at pre-determined
times post-infection by cervical dislocation. Lungs were removed
and either homogenised for CFU counts and ELISA or prepared
for flow cytometry by incubation for 30 min at 37uC with 10 mg/
ml collagenase D [Amersham], followed by homogenization and
lysis of erythrocytes [12].
Bacterial Counts
Serial dilutions to 1027 made using 20 ml samples of homog-
enised lung were analysed in sterile 96-well microtiter plates
[GIBCO, Paisley, United Kingdom] containing 180 ml of sterile
nanopure water per well. Pseudomonas selective agar plates were
marked into six sectors, and three 20 ml aliquots of each dilution
were plated into each sector; this procedure was repeated in
duplicate. Once dry, plates were incubated at 37uC overnight.
Colonies were counted in sectors containing a measurable number
[approximately ,300].
Flow cytometry
Mouse tissue cell suspensions, at 26108 cells/ml, were
incubated with purified anti-Fc receptor blocking antibody [anti-
CD16/CD32] before addition of the specific antibodies. Cell
surface markers were stained using a combination of fluorescein
isothiocyanate [FITC]-, phycoerythrin [PE]-, PE-Cy7- and
allophycocyanin [APC]-conjugated monoclonal antibodies direct-
ed against: T-cells CD3 [clone 17A2], CD4 [GK1.5], CD8 [53-
6.7], B-cells CD19 [1D3], Neutrophils Gr-1 [RB6-8C5], Macro-
phages F4/80 [BM8]. Where appropriate, CD45 [30-F11] was
used to identify haematopoietic cells. In each experiment the
appropriate isotype control monoclonal antibodies and single
conjugate controls were also included. All antibodies were
purchased from eBioscience. Samples were analysed using a
Becton Dickinson FACScalibur flow cytometer running CellQuest
acquisition and analysed using FlowJo software [version 8.8.3,
Tree Star].
ELISA assays
Lung homogenates were prepared in ice cold PBS containing a
protease inhibitor cocktail before being clarified by centrifugation
for five minutes at 4uC. Total protein concentrations were
determined by using a DC protein assay kit [Biorad] according
to the manufacturer’s instructions and expression per milligram of
lung homogenate calculated. Chemokines CXCL13, CCL19 and
CCL21 were measured using DuoSet ELISA assays as described
by the manufacturer [R&D systems] and both murine and human
BAFF using quantikine ELISA kits [R&D systems].
Statistical Analysis
Data were analyzed using independent samples t tests or Mann-
Whitney U tests depending on data distribution determined by the
1-sample Kolmogorov-Smirnov test. Data were analyzed using
SPSS 20 software [SPSS Inc].
BAFF in Pseudomonas aeruginosa Infection
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Results
BAFF Expression in Cystic Fibrosis Patient
Bronchoalveolar Lavage
To determine if BAFF expression is a characteristic of human
lung bacterial infection, BAFF was measured in BAL from 20
school age children with CF [mean [SD] age, 8.0 [4.5] years].
Samples from six of these children were obtained bronchoscopi-
cally when they were being investigated for persistent respiratory
symptoms. Samples from the remaining 14 CF patients and 7
healthy control children [6.8 [3.5] years] were obtained non-
bronchoscopically when these children attended hospital for
routine elective surgery. BAL from six of the CF patients cultured
P. aeruginosa, with the remainder being culture positive for other
organisms including Haemophilus influenzae, Stenotrophomonas mal-
tophilia and Aspergillus species [n = 6] or BAL fluid culture negative
[n = 8] [a full list of all organisms is available in Table S1]. BAFF
expression was significantly elevated in both P. aeruginosa positive
and negative patient groups [p,0.01] compared to the control
group [Figure 1].
Figure 1. BAFF expression in BAL fluid. Expression was measured by ELISA in BAL fluid from P. aeruginosa positive [n = 6] and negative [n = 14]
CF patients and healthy controls [n = 7]. BAFF expression was significantly elevated [p,0.01] in both the PA infected group and non PA infected
group in comparison to the control group.
doi:10.1371/journal.pone.0095892.g001
Figure 2. Kinetics of airway infection by P. aeruginosa LESB65. Mice were challenged [intranasal] with 106 CFU. Values shown as an average
Log CFU/mg of lung tissue homogenised, n = 5 mice at each time point. Time zero samples were taken at 15 minutes post infection to confirm entry
into the lung and determine levels immediately post infection.
doi:10.1371/journal.pone.0095892.g002
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Bacterial Infection and Cellular Infiltration in a murine
respiratory inhalation model of P. aeruginosa infection
A murine respiratory infection model was used to assess the
inflammatory response to stable P. aeruginosa LESB65 strain
infection in lungs. Balb/c mice were challenged intranasally and
lung bacterial load and inflammatory cell infiltration monitored
over a 7 day period post-infection. As shown in Figure 2, challenge
with LESB65 resulted in stable infection of the bacteria within the
lung with CFU/mg of tissue initially Log 4, Log 3.2 at 48 hours
and Log 4.5 at day 7 post-challenge. LESB65 was restricted to the
lungs and no bacteria were recovered from blood at any time point
post infection.
Measurement of the inflammatory cell response showed the
predominant cell infiltrating the lung at early time points to be
neutrophils. A peak of 1500 cells/mg tissue being obtained at
24 hours post infection with significantly elevated numbers present
at 24 hours [P,0.01] and 48 hours [P,0.01] but not at 72 hrs
[Figure 3 and 4]. In contrast, B cells, and CD4 and CD8 T
lymphocyte numbers increased with significantly elevated numbers
at 72 hours post infection [B cells P,0.01, CD4 P,0.01, CD8 P,
0.05] with CD4 cells being the predominant T cell type [Figure 3
and 4]. B lymphocytes and CD4 T cells numbers reached 800
cells/mg of lung tissue by 3 days post-infection [Figure 3 and 4]
with CD8 cell numbers being consistently lower.
Expression of mBAFF and Lymphoid Cell
Chemoattractants CXCL13, CCL19 and CCL21
To determine if increased expression of BAFF is also a feature of
the response to airway P. aeruginosa infection in this murine model
system, mean [SD] protein levels were measured in lung
homogenate samples prepared from mice at day 0 and at 1, 2, 3
and 7 days post infection [all n = 5]. BAFF was found to be
significantly elevated at day 1 [892 [199] pg/ml p,0.001], day 2
[750 [242] pg/ml p,0.01], day 3 [1081 [214] pg/ml p,0.001]
and day 7 [386 [64] pg/ml p,0.05] [Figure 5].
Expression of the chemoattractants CXCL13, CCL19 and
CCL21 were measured to assess how B lymphocytes could be
recruited into the lung [Figure 5]. Highest expression of CXCL13
was observed on days 1 [Mean [SD], 521 [179] pg/ml] and 2 [523
[152] pg/ml] post infection with levels decreasing progressively to
day 7 when they were still above control values [P,0.005]. In
contrast, CCL19 and CCL21 expression reached peak values,
Figure 3. FACS analysis of lung inflammatory cells following P. aeruginosa LESB65 infection of mice. Representative FACS plots showing
immune cell staining of airway cells. Each column shows plots from an individual mouse at each time point. All plots are lung CD45+ cells and gates
were drawn relative to isotype control antibody staining for each marker. Top row shows B cells [CD45+, CD19+], middle row shows CD4 T cells
[CD45+, CD3+, CD4+] and CD8 T cells [CD45+, CD3+, CD8+], bottom row shows neutrophils [CD4+, Gr-1hi, F4/80-] and monocytes/macrophages
[CD45+, F4/80+, Gr-1int/low]. Numbers on gates are percentages of total CD45+ cells.
doi:10.1371/journal.pone.0095892.g003
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mean [SD], at day 7, [94 [24] pg/ml and 223 [64] pg/ml
respectively], CCL19 being significantly elevated compared to
control from day 1, mean [SD] 204 [6.5] pg/ml, [p value ,0.01],
but CCL21 being significantly elevated only from day 2 onwards
[P,0.001].
Discussion
Although many studies have focused on the mechanism and
importance of inflammatory cell recruitment into the lung
following P. aeruginosa infection, few studies have examined the B
cell response within the airway. Here we demonstrate, to our
knowledge for the first time, that BAFF expression is increased in
BAL from the lungs of patients with CF. Furthermore, using a
respiratory inhalation model of stable long-term lung infection
with P. aeruginosa LESB65 in mice, we show, to our knowledge for
the first time, recruitment of both B and T lymphocytes,
expression of the B cell chemo-attractant cytokines CXCL13,
CCL19 and CCL21 and up-regulation of the B cell differentiation
factor BAFF.
We have previously shown that the B cell differentiation factor
BAFF, a major B cell growth factor that promotes B cell
maturation and antibody production is expressed in the human
airway during a range of viral infections including respiratory
syncytial virus [6]. To determine if BAFF expression is a
component of the human airway response to P. aeruginosa infection,
we measured BAFF expression in BAL from children with CF
both with and without P. aeruginosa infection. Both groups showed
significant elevation in BAFF expression in comparison to the
control group. The P. aeruginosa negative CF patient group, some
of whom were culture positive for other bacterial infections, also
showed elevated BAFF expression, indicating that this response is
not P. aeruginosa-specific. The recent observation that BAFF is
expressed during Mycobacterial infection is consistent with this
suggestion [13]. Furthermore, our previous finding that BAFF
expression occurs in response to a range of viral infections [6],
supports this being a general mechanism in airway defence. The
findings presented here cannot discount the possibility that
elevated BAFF expression may be an innate characteristic of the
CF airway associated with the underlying CFTR defect or of
immune or inflammatory processes within the CF airway.
To further determine if expression of this B cell differentiation
factor correlated with increased expression of B cell recruitment
factors and increased B cell numbers in the lung, we used an
animal model of chronic pseudomonas infection. Neutrophils were
the major inflammatory cell recruited to the lung, with numbers
peaking at day 1 post-challenge before reducing at days 2 and 3.
The 24–48 hour peak of neutrophil influx coincides with a
significant drop in bacterial load in the lung and the subsequent
decline in lung neutrophil numbers is matched by a corresponding
steady decrease in bacterial CFUs. This pattern of rapid
neutrophil influx and gradual decline is in keeping with other
respiratory pathogen infection models of the lungs e.g. strepto-
coccus pneumonia, where early and rapid neutrophil influx is
ineffectual in clearance and containment of bacterial loads [14]. In
contrast, B cell and T cell [both CD4 and CD8] influx into the
Figure 4. Airway leukocyte number following LESB65 infection. Average B lymphocyte, CD4+ve T cell, CD8+ve T cell and neutrophil count
shown as mean and standard deviation per mg of tissue at 24, 48, and 72 hours post infection [N= 5 each time point]. * = p,0.05, ** = p,0.01.
doi:10.1371/journal.pone.0095892.g004
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lung progressively increased over the study period of 7 days post-
infection. To our knowledge no previous studies have documented
B cell recruitment into the lung following P aeruginosa infection. In
contrast, T cell responses have been studied with CD4 cell Th2
and Th17 type responses being described in human P. aeruginosa
infection [15–17], while CD4 Th1 cells have been reported to be
protective in mice [18].
In order to understand better how the observed recruitment of
B and T cells into the lungs is mediated, we looked at expression of
the homeostatic chemokines, CXCL13, CCL19 and CCL21,
known to influence lymphocyte migration and to be expressed by
epithelial, endothelial and dendritic cells [7,19]. Increased
CXCL13 expression from day 1 post infection preceded increased
CCL19 and CCL21. Elevation of CXCL13, primarily a B cell
chemoattractant with highest expression on days 1 and 2
coincided with the increase in B cell numbers, suggesting that
this chemoattractant may be important in the local B cell response
to P. aeruginosa, possibly supporting the recruitment of both B1 and
B2 B cell types [19].
In contrast, expression of the B cell, T cell and DC
chemoattractants CCL19 and CCL21 increased progressively to
7 days post infection with CCL19 elevated at day 1 and rising
before CCL21. A previous study, using the PAO1 strain, reported
increased expression of CCL19 but not CCL21 on day 1 following
P. aeruginosa infection but did not study later time points [8]. The
data presented here show that both are upregulated post infection
but with differential kinetics, CCL19 levels initially being increased
before CCL21, although CCL21 is expressed at higher levels by
day 7. Our data supports a role for these two chemokines in later
recruitment of B and T lymphocytes and potentially DCs whilst
CCL19 could also have a role in the early recruitment of B cells.
CXCL13, CCL19 and CCL21 have previously been shown to be
essential components of the local airway immune response to viral
infection [7] and to be involved in iBALT formation, a recognised
feature of long term pathogen exposure [20]. It is possible that
recruitment of both B and T cells seen in this study represents the
early stages of iBALT formation and the induction of a local
adaptive immune response.
Our results demonstrate that increased BAFF expression is a
characteristic of the airway immune response at similar time points
to increased expression of B cell chemoattractant and elevated B
cell numbers. This suggests that not only are B cells recruited to
the airway but that the local environment is capable of supporting
B cell survival, differentiation and antibody production.
Figure 5. Expression of BAFF, CXCL13, CCL19 and CCL21 in mouse lung tissue. Each cytokine was measured at days 1, 2, 3 and 7 days after
infection with 106 CFU of P. aeruginosa LESB65 by ELISA. [n = 5]. BAFF was significantly expressed at days 1 [p,0.001], 2 [p,0.01], 3 [p,0.001], and 7
[p,0.05] in comparison to day 0 control. CXCL13 at days 1, 2, 3, [all p,0.001] and 7 [p,0.01]. CCL19 at days 1 [p,0.01], 2 [p,0.001], and 7 [p,0.001].
CCL21 at days 2 [p,0.001], 3 [p,0.01] and 7 [p,0.001]. * = p,0.05, ** = p,0.01, *** = p,0.001.
doi:10.1371/journal.pone.0095892.g005
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That airway BAFF can act to promote antibody secretion is
supported by previous work showing BAFF, when used as an
adjuvant in mucosal immunisation with heat killed Pseudomonas,
resulted in increased antibody production [9]. The mechanism
leading to expression of BAFF in the mouse airway in response to
P. aeruginosa has not been defined here. In viral infection it is
expressed by infected epithelial cells and dependent on interferon
beta production [6,21]. Airway epithelial cells from CF patients
have been shown to produce less interferon in response to viral
infection [22,23]. If a similar mechanism occurs in response to
bacterial challenge, reduced levels of BAFF and consequent lower
local antibody production may be a further factor compromising
airway defence in this patient group.
Collectively our results demonstrate differential expression of
both B and T lymphocyte chemoattractants, recruitment of B cells
and significant expression in both mouse and humans of the key
differentiation factor BAFF, potentially capable of supporting B
cell maturation in the lung.
Supporting Information
Table S1 Additional Bacteria identified in patient BAL
samples and respective P. aeruginosa status for each
patient.
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